Right Ventricular Pressure–Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure
Section snippets
Hemodynamic and Echocardiographic Ramp Test
Four patients who received a HeartMate 3 device (Abbott Laboratories, Abbott Park, IL) underwent a combined hemodynamic and echocardiographic speed optimization test within 12 months of LVAD implantation (Figure 1). All participants were stable outpatients and had a clinical indication for a follow-up right heart catheterization with LVAD speed optimization. On the day of the procedure, they consented to participate in the research protocol. To participate in the study, patients had to have an
Hemodynamic and Echocardiographic Ramp Test
Hemodynamic and echocardiographic measurements were obtained in 4 consecutive patients who presented for clinically indicated ramp tests. Patients 1 and 3 underwent ramp tests as part of routine surveillance within 6 months of LVAD implantation, and patients 2 and 4 both were undergoing a workup for recurrent low-flow alarms. Baseline characteristics are provided in Table 1. Age ranged from 22 to 69 years and 1 of the 4 patients was female. The indication for device implantation was ischemic
Discussion
In this pilot study, we performed novel, multimodality ramp studies in HeartMate 3 recipients combining pulmonary arterial catheter-derived hemodynamics, 3-dimensional echocardiography, and invasive PV analysis. Furthermore, we used computational modeling to derive important insights into the complex interplay between interventricular interactions and RV function in LVAD recipients. Our key findings were 3-fold. First, despite the small sample size, we observed 3 patterns of interventricular
Conclusions
Previous investigations implied that increasing LVAD speed had no effect on the RV PV loop,20 but we identified additional patterns that included predominant diastolic interventricular interactions and combined systolic and diastolic interactions. The use of computational modeling put these findings into perspective by helping to identify the contributions of serial and parallel ventricular interactions in the setting of LVAD speed variations. These findings are novel and set the stage for
Disclosures
M.K. Kanwar is on the Advisory board for Abiomed, Bayer, and CareDx. P.C. Colombo reports consulting fees from Abbott. G.T. Sayer reports consulting fees from Abbott. N. Uriel reports consulting fees from Medtronic and honorarium from Abbott. D. Burkhoff reports consulting fees from PVLoops and Cardiodyme, and grant support from Abiomed. The remaining authors have stated that they have no conflicts of interest.
Funding
M.I. Brener is supported by NIH (NHLBI) T32HL007343.
References (20)
- et al.
Clinical outcomes associated with INTERMACS-defined right heart failure after left ventricular assist device implantation
J Heart Lung Transplant
(2017) - et al.
Right ventricular failure after left ventricular assist devices
J Heart Lung Transplant
(2015) - et al.
Systolic ventricular interaction in normal and diseased explanted human hearts
J Thorac Cardiovasc Surg
(1997) - et al.
Hemodynamic ramp tests in patients with left ventricular assist devices
JACC Heart Fail
(2016) - et al.
3D morphological changes in LV and RV during LVAD ramp studies
JACC Cardiovasc Imaging
(2018) - et al.
Hemodynamics of mechanical circulatory support
J Am Coll Cardiol
(2015) - et al.
Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3)
J Heart Lung Transplant
(2017) - et al.
New insights into right ventricular function among patients with left ventricular assist devices using high fidelity conductance catheters to generate real time pressure volume loops
J Heart Lung Transplant
(2019) - et al.
Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function
Prog Cardiovasc Dis
(1998) - et al.
Investigating the role of interventricular interdependence in development of right heart dysfunction during LVAD support: a patient-specific methods based approach
Front Physiol
(2018)
Cited by (13)
Acute right ventricular geometric change predicts outcomes in HeartMate 3 patients
2024, Journal of Heart and Lung TransplantationOccult right ventricular dysfunction and right ventricular-vascular uncoupling in left ventricular assist device recipients
2024, Journal of Heart and Lung TransplantationBiventricular catheterization combined with pressure-volume loop monitoring provides insight into the dynamic effects of left ventricular assist devices ramp on right ventricular function
2024, Catheterization and Cardiovascular Interventions
Lay Summary
A left ventricular assist device can be a life-saving treatment for patients with advanced heart failure symptoms. Although the left ventricular assist device offloads the weakened left ventricle by taking blood out from the ventricle and pumping it to the rest of the body, the right ventricle (RV) often suffers and, when it does, this leads to many adverse outcomes. Further complicating matters, physicians have difficulty predicting and treating RV dysfunction. Thus, we used a specialized conductance catheter that measures pressure and volume simultaneously in the RV to understand, at a mechanistic level, how the RV responds to left ventricular assist device implantation.